@ARTICLE{
author={Kulkarni R,Karim Abdul F,Glamocanin S,Janic Dragana M,Vdovin V,Ozelo M,Rageliene L,Carboni E,Laguna P,Dobaczewski G,Seremetis S,Lindblom A,Santagostino E},
year={2013},
title={Results from a large multinational clinical trial (guardian (TM) 3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics},
journal={HAEMOPHILIA},
volume={19},
number={5},
pages={698-705},
document_type={Article},
} 

@ARTICLE{
author={Lentz SR,Misgav M,Ozelo MC,Salek SZ,Veljkovic Dobrila K,Recht M,Cerqueira MH,Tiede Andreas,Brand B,Mancuso ME,Seremetis S,Lindblom A,Martinowitz U},
year={2013},
title={Results from a large multinational clinical trial (guardian (TM) 1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy},
journal={HAEMOPHILIA},
volume={19},
number={5},
pages={691-697},
document_type={Article},
}